Literature DB >> 24166082

Viral hepatitis: eltrombopag is useful for patients with HCV and thrombocytopenia.

Isobel Leake.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24166082     DOI： 10.1038/nrgastro.2013.212

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  1 in total

1.  Eltrombopag increases platelet numbers in thrombocytopenic patients with HCV infection and cirrhosis, allowing for effective antiviral therapy.

Authors:  Nezam H Afdhal; Geoffrey M Dusheiko; Edoardo G Giannini; Pei-Jer Chen; Kwang-Hyub Han; Aftab Mohsin; Maribel Rodriguez-Torres; Sorin Rugina; Igor Bakulin; Eric Lawitz; Mitchell L Shiffman; Ghias-Un-Nabi Tayyab; Fred Poordad; Yasser Mostafa Kamel; Andres Brainsky; James Geib; Sandra Y Vasey; Rita Patwardhan; Fiona M Campbell; Dickens Theodore
Journal:  Gastroenterology       Date:  2013-10-12       Impact factor: 22.682
  1 in total
  1 in total

1.  Promoting platelets is a therapeutic option to combat severe viral infection of the lung.

Authors:  Jiahuang Qiu; Juan Ma; Shuping Zhang; Jinxiang Han; Sijin Liu
Journal:  Blood Adv       Date:  2020-04-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.